Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity

Magnetic Resonance Imaging

Volumn 27, Issue 6, 2009, Pages 801-806

  Tanabe, Masahiro ^a   Ito, Katsuyoshi ^b   Shimizu, Ayame ^a   Fujita, Takeshi ^a   Onoda, Hideko ^a   Yamatogi, Shigenari ^a   Washida, Yasuo ^a   Matsunaga, Naofumi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Adequate MR sequence; Dysplastic nodule; SPIO enhanced MRI; Well differentiated hepatocellular carcinoma

Indexed keywords

FERUCARBOTRAN; NONIONIC CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IRON TRANSPORT; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NODULE; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SIGNAL NOISE RATIO;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; CONTRAST MEDIA; FEMALE; HEPATITIS; HUMANS; IMAGE ENHANCEMENT; IRON; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 67349154109     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.11.006     Document Type: Article

References (20)

1. Semelka R.C., and Helmberger T.K. Contrast agents for MR imaging of the liver. Radiology 218 (2001) 27-38
2. Reimer P., and Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13 (2003) 1266-1276
3. Tanaka M., Nakashima O., Wada Y., Kage M., and Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24 (1996) 807-812
4. Grandin C., Van Beers B.E., Robert A., Gigot J.F., Geubel A., and Pringot J. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 19 (1995) 412-418
5. Takeshita K., Nagashima I., Frui S., Takada K., Yamauchi T., Harasawa A., et al. Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule. J Comput Assist Tomogr 26 (2002) 451-455
6. Imai Y., Murakami T., Yoshida S., Nishikawa M., Ohsawa M., Tokunaga K., et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32 (2000) 205-212
7. Ishida T., Murakami T., Kato N., Takahashi M., Miyazawa T., Tsuda K., et al. Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule. Invest Radiol 32 (1997) 282-287
8. Paley M.R., Mergo P.J., Torres G.M., and Ros P.R. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. AJR Am J Roentgenol 175 (2000) 159-163
9. Lim J.H., Choi D., Cho S.K., Kim S.H., Lee W.J., Lim H.K., et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220 (2001) 669-676
10. Ward J., Guthrie J.A., Wilson D., Arnold P., Lodge J.P., Toogood G.J., et al. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging - comparison of optimized sequences. Radiology 228 (2003) 709-718
11. Kim M.J., Kim J.H., Choi J.Y., Park S.H., Chung J.J., Kim K.W., et al. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 187 (2006) W255-W266
12. Matsuo M., Kanematsu M., Itoh K., Murakami T., Maetani T., Kondo H., et al. Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs. AJR Am J Roentgenol 182 (2004) 235-242
13. Yoshikawa T., Mitchell D.G., Hirota S., Ohno Y., Oda K., Maeda T., et al. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions. J Magn Reson Imaging 23 (2006) 712-719
14. Kim J.H., Kim M.J., Suh S.H., Chung J.J., Yoo H.S., and Lee J.T. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 15 (2002) 573-583
15. Kim S.H., Choi D., Lim J.H., Lee W.J., Jang H.J., Lim H.K., et al. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences. Korean J Radiol 3 (2002) 87-97
16. Kanematsu M., Itoh K., Matsuo M., Maetani Y., Ametani F., Kondo H., et al. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences. J Magn Reson Imaging 13 (2001) 249-257
17. Nakayama M., Yamashita Y., Mitsuzaki K., Yi T., Arakawa A., Katahira K., et al. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging 11 (2000) 647-654
18. Sugihara S., Suto Y., Kamba M., and Ogawa T. Comparison of various techniques of iron oxide-enhanced breath-hold MR imaging of hepatocellular carcinoma. Clin Imaging 25 (2001) 104-109
19. Poeckler-Schoeniger C., Koepke J., Gueckel F., Sturm J., and Georgi M. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imaging 17 (1999) 383-392
20. Van Beers B.E., Lacrosse M., Jamart J., Grandin C., Gigot J.F., Horsmans Y., et al. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. AJR Am J Roentgenol 168 (1997) 713-717